Nikita pawar

MBBS, MD Medicine (LTMMC)
Nephrologist and Transplant Physician (SGRH, Delhi)
NSMC intern 2023
Connecting dots...always ready to learn.💫

[Purva B. N @purvabavikar]

50 Shades of #Interventional #Nephrology!
🖲️ Managing ICU fluid status (POCUS, VExUS, Dopplers)
🤛 Creating AV fistulas, mastering tunnelled catheters, embracing PD
👩‍🔬 Salvaging veins in the cath lab & performing ENDO-AVF #AVATAR2025

[Priya John🇮🇳 @drpriyajohn]

Grateful for the opportunity to be part of the ABOi Transplant Symposium. My sincere thanks to @VinBhargava and the @AVATAROrg team. One Great learning experience!!
It was wonderful reconnecting with my teachers and colleagues

[Vineet Behera @BeheraVineet]

Our novel technique for Cuff Extrusion Tunneled Dialysis catheter

🔥CEET : Catheter Exchange with Elongation Tunnel

Our initial experience published in Seminars in Dialysis
https://t.co/meDf3vwkk5

@isn_india @InformNephro @ASDINNews @AVATAROrg @indianjnephrol @ISNeducation

[Dr. Medica🩺 @DrMedica_13]

#Becareful 🔴 ⚠️

Stroke. Vertebral artery dissection.

Very common at chiropractor clinics, spa massage centres, Barbar shops, and street massagers!

#NeuroMed #MedEd #MedX

[Nico Gagelmann @NicoGagelmann]

Harrison is one of the most amazing teaching books ever produced

A short thread on brilliant educational algorithms in internal medicine

[Arvind Canchi (Conjeevaram)🇮🇳 @arvindcanchi]

💥There was no evidence that HIF prolyl hydroxylase inhibitors and ESA had different effects on MACE in people with dialysis-dependent CKD or people with nondialysis-dependent CKD.
💥There was no evidence that HIF PHI and placebo had different effects on MACE in people with nondialysis-dependent #CKD.
💥The lack of difference between HIF PHI and ESA or placebo was observed for individual components of MACE and cardiovascular death.
💥 In nondialysis-dependent CKD, #dialysis access thrombosis, venous thromboembolism, infections, and hyperkalemia occurred more frequently with HIF prolyl hydroxylase inhibitors in placebo-controlled trials but not in ESA-controlled trials.
https://t.co/QVq0QfsW4K

[KIReports @KIReports]

#Statin use and the Progression of Coronary Artery Calcification #CAC in Chronic Kidney Disease #CKD: Findings from the KNOW-CKD Study

#VisualAbstract by @Nikitap159

https://t.co/7tWeJossIF

[Sundar Sankaran @sundar_s1955]

End of an Era and End of a Legend whose Influence on us Nephrologists is immense
Barry Brenner
Brenner s Trade off hypothesis holds good not just in Renal Physiology but in our day to day life too
#Kidney @isn_india
#Nephrology
Brenner s text book on Kidney is our Bible and Bhagavat Geeta

[Jasmine Sethi @JasmineNephro]

🔟Takeways of @goKDIGO lupus nephritis guidelines

Slide by @stephanietr612 #GlomConHawaii @GlomCon

[Stephanie Torres M.D. @stephanietr612]

Clinical Management of C3/TMA
🗣️ Dr. Carla Nester

C3G
🩺 When C3 is in the ddx - rule out infection 🦠
🩺⬆️ disease burden
🩺If patient is older - it is paraprotein until proven otherwise
🩺Current tx recommendations 📷⬇️

#GlomConHawaii

[KIReports @KIReports]

Increased Blood-Brain Barrier #BBB Permeability and #CognitiveImpairment in Patients With #ESKD

#VIsualAbstract by @Nikitap159

https://t.co/VMiEDkZ74W

@Mickael_Bob @SBurtey @NJourde

[Stephanie Torres M.D. @stephanietr612]

🌟 Top 1️⃣0️⃣ takeaways for the management of ANCA Associated Vasculitis (AAV) 🌟

#GlomConHawaii

[JASN_News @JASN_News]

SPRINT showed that intensive lowering of systolic BP increased the risk of incident CKD and episodes of AKI. A study looked at legacy effect of intensive vs. standard systolic BP lowering on longer-term incidence of kidney failure. Rates of dialysis or transplantation were higher with intensive treatment, but differences were small https://t.co/XX0xO30zny

[KIReports @KIReports]

Clinicopathologic Features of #Kidney Disease in Patients With Cystic Fibrosis

https://t.co/K0XU5mb666

#KIRResearchLetter #CysticFibrosis

[Nikita pawar @Nikitap159]

Happy to be part of this team!
@aksrulz13 @doc_nephron @drvivekgoel @VinBhargava @anandthedoc @Jithukurian6 @aakashshingada @DrNeilSaldanha @AnkitCare @iamnephrologist @happiedoc @krithicism @DrPallaviPrasad @nephromythri @drpriyajohn

[Umesh Khanna @Ubkhanna]

👆🏻MKF academy website is here!
👆🏻All in one Nephro library! Easy to find, segregated academic content.
💥Nephrology Observership & mentorship programs at prestigious institutes
💥Journal scan & Visual abstracts
Nephrology library
Here’s the link
https://t.co/qco2YWI2gB

[Umesh Khanna @Ubkhanna]

👆🏻MKF academy website is here!
👆🏻All in one Nephro library! Easy to find, segregated academic content.
💥Nephrology Observership & mentorship programs at prestigious institutes
💥Journal scan & Visual abstracts
Nephrology library
Here’s the link
https://t.co/qco2YWI2gB

[Nikita pawar @Nikitap159]

✨Great initiative by Mumbai Kidney Foundation.
✨Nephro academic website for everyone.
Thanks to Dr Umesh Khanna 🙏@Ubkhanna

[Vineet Behera @BeheraVineet]

MKF Academy website, an academic initiative #MKF @mkfindia launched #AVATAR2024 @Ubkhanna @AVATAROrg
Contains
⚡Nephrology library (35 topics)
⚡Observer Programs Nephro
⚡Mentorship modules
⚡Journal Scan
⚡Modules -Dieticians, technicians
Please join
https://t.co/tAtGqZWw4F

[Sanjeev Sethi @SethiRenalPath]

Teaching C1q in glomeruli on immunofluorescence microscopy.

My experience is if + it is real & is not non specific.

Positive:
1. Autoimmune disease=always +
2. Monoclonal Ig (PGNMID/MIDD)=often +
3. Infections= can be + or -

Negative:
1.IgA nephropathy
2.C3 glomerulopathy

[Vaibhav Tiwari @drvt87]

NELL-1 Associated Membranous Nephropathy (MN) Case Series from India

🚀 New insights on NELL-1 Associated Membranous Nephropathy (MN) from India! Dive into our recent case series highlighting the significance of NELL-1 in PLA2R-negative MN cases.